GlassScriptPhysician profile
Elliot Nussbaum
NPI 1023654050
$1,175.64
in general payments reported to CMS, 2019-2025
17 companies · $686 in 2025
The $686 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.01 · 2023: $117 · 2024: $328 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,131.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $446.49 | 2024-2025 | Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan, Mycarelink |
| Altathera Pharmaceuticals LLC | $162.63 | 2024 | Sotalol Hydrochloride |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $82.86 | 2021-2024 | Lifevest |
| Boston Scientific Corporation | $76.88 | 2024-2025 | Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $76.75 | 2025 | Jot Dx, Amplatzer |
| Pfizer INC. | $72.05 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $46.02 | 2023-2025 | Optimizer, Optimizer |
| Davol INC. | $32.40 | 2025 | Arista |
| Lexicon Pharmaceuticals, INC. | $28.58 | 2023 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $23.21 | 2023 | Arcalyst |
| Amgen INC. | $20.13 | 2024 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $19.38 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.72 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $18.42 | 2025 | |
| Irhythm Technologies, INC. | $17.69 | 2024 | Zio Xt Patch, Zio Monitor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.45 | 2025 | Mounjaro, Zepbound |
| Kestra Medical Technology Services, INC. | $15.98 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Nussbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.